
Prostate Cancer: National Guidelines Have Not Stopped Overuse of Low-Value PSA Screening in Older Males
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LABORATORY INDUSTRY REPORT
NATIONAL LAB REPORTER
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.
Recently released AACC document covers newly updated screening guidelines as well as information on surveillance and diagnosis.
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.